Legal Opinion
Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc.
Court of Appeals for the Federal Circuit
Decided September 23, 2025No. 23-2434Published
1Opinion of the Court
Case: 23-2434 Document: 78 Page: 1 Filed: 09/23/2025 United States Court of Appeals for the Federal Circuit ______________________ BAYER PHARMA AKTIENGESELLSCHAFT, Appellant v. MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA, INC., INVAGEN PHARMACEUTICALS INC., Appellees ______________________ 2023-2434 ______________________ Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2022- 00517, IPR2022-01513, IPR2022-01515. ______________________ Decided: September 23, 2025 ______________________ DOV PHILIP GROSSMAN, Williams & Connolly LLP,…
2Cases cited11 opinions
- Becton, Dickinson & Co. v. Tyco Healthcare Group, LPCourt of Appeals for the Federal Circuit · 2010
- In Re: Nuvasive, Inc.Court of Appeals for the Federal Circuit · 2016
- King Pharmaceuticals, Inc. v. Eon Labels, IncCourt of Appeals for the Federal Circuit · 2010
- In Re Huai-Hung KaoCourt of Appeals for the Federal Circuit · 2011
- Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2014
6 more not listed; retrieve them via the Exa API.